Literature DB >> 33654804

In vitro and in vivo Assessment of Protein Acetylation Status in Mycobacteria.

Krishna K Singh1,2, Devendra P Singh1, Rambir Singh2, Deepak K Saini1,3.   

Abstract

Protein acetylation is one of the standard post-translational modifications found in proteins across all organisms, along with phosphorylation which regulates diverse cellular processes. Acetylation of proteins can be enzymatically catalyzed through acetyltransferases, acetyl CoA synthetases or non-enzymatically through acyl carrier metabolic intermediates. In this protocol, using response regulator proteins as targets we describe the experimental strategy for probing the occurrence of acetylation using purified recombinant proteins in an in vitro setup. Further using M. smegmatis strains overexpressing the wild type or mutant response regulator protein, we also describe how in vivo acetylation can be validated in Mycobacterial proteins. The described approach can be used for analyzing acetylation of any mycobacterial protein under both in vitro and in vivo conditions.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Acetylation; KATms; M. tuberculosis; Post-translational modification; Response regulator; TcrX; Two-component signaling

Year:  2019        PMID: 33654804      PMCID: PMC7854051          DOI: 10.21769/BioProtoc.3291

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  9 in total

1.  Chaperonins govern growth of Escherichia coli at low temperatures.

Authors:  Manuel Ferrer; Tatyana N Chernikova; Michail M Yakimov; Peter N Golyshin; Kenneth N Timmis
Journal:  Nat Biotechnol       Date:  2003-11       Impact factor: 54.908

2.  cAMP-regulated protein lysine acetylases in mycobacteria.

Authors:  Subhalaxmi Nambi; Nirmalya Basu; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

3.  The two-component signalling networks of Mycobacterium tuberculosis display extensive cross-talk in vitro.

Authors:  Ruchi Agrawal; Akancha Pandey; Mayooreshwar P Rajankar; Narendra M Dixit; Deepak K Saini
Journal:  Biochem J       Date:  2015-05-01       Impact factor: 3.857

4.  Quantitation of protein.

Authors:  C M Stoscheck
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Acetylome analysis reveals diverse functions of lysine acetylation in Mycobacterium tuberculosis.

Authors:  Fengying Liu; Mingkun Yang; Xude Wang; Shanshan Yang; Jing Gu; Jie Zhou; Xian-En Zhang; Jiaoyu Deng; Feng Ge
Journal:  Mol Cell Proteomics       Date:  2014-09-01       Impact factor: 5.911

6.  Acetylation of Response Regulator Proteins, TcrX and MtrA in M. tuberculosis Tunes their Phosphotransfer Ability and Modulates Two-Component Signaling Crosstalk.

Authors:  Krishna Kumar Singh; Neerupma Bhardwaj; Gaurav D Sankhe; Niveda Udaykumar; Rambir Singh; Vandana Malhotra; Deepak Kumar Saini
Journal:  J Mol Biol       Date:  2019-01-09       Impact factor: 5.469

7.  Proteome-wide lysine acetylation profiling of the human pathogen Mycobacterium tuberculosis.

Authors:  Longxiang Xie; Xiaobo Wang; Jie Zeng; Mingliang Zhou; Xiangke Duan; Qiming Li; Zhen Zhang; Hongping Luo; Lei Pang; Wu Li; Guojian Liao; Xia Yu; Yunxu Li; Hairong Huang; Jianping Xie
Journal:  Int J Biochem Cell Biol       Date:  2014-11-29       Impact factor: 5.085

8.  Lysine acetylation of DosR regulates the hypoxia response of Mycobacterium tuberculosis.

Authors:  Hua Yang; Wei Sha; Zhonghua Liu; Tianqi Tang; Haipeng Liu; Lianhua Qin; Zhenling Cui; Jianxia Chen; Feng Liu; Ruijuan Zheng; Xiaochen Huang; Jie Wang; Yonghong Feng; Baoxue Ge
Journal:  Emerg Microbes Infect       Date:  2018-03-21       Impact factor: 7.163

9.  Acetylation of lysine 182 inhibits the ability of Mycobacterium tuberculosis DosR to bind DNA and regulate gene expression during hypoxia.

Authors:  Jing Bi; Zongchao Gou; Fengzhu Zhou; Yiqing Chen; Jianhua Gan; Jun Liu; Honghai Wang; Xuelian Zhang
Journal:  Emerg Microbes Infect       Date:  2018-06-13       Impact factor: 7.163

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.